U.S. government agencies publish compliance note for foreign persons regarding sanctions and export controls; The European Union to ban products made with forced labor; and U.S. bill aims to protect data that would reveal the personal health and genetic information of Americans.
Chinese court rules against an AI platform for copyright infringement for the first time; the U.S. Department of Commerce opens consultation for the restrictions on Chinese electrical vehicles; and Chinese IP Court imposes punitive damages to stop seed IP infringement
In 2023, the healthcare industry in China was subject to significant legislative advancements and reforms aimed at addressing industry concerns and promoting innovation. Hanshuo Zhou and Xiaoyun Wang of Jingtian & Gongcheng summarize the key events, and provide a reflective review based on their' practical experience
Shanghai plans a three-tiered cross-border data flow regime in the Lingang free trade zone to boost foreign investment; the U.S. proposes a "know your customer" regulation for cloud computing companies over China AI concerns; and a bill introduced in Congress called the BIOSECURE Act, is designed to broaden current sanctions on China
U.S. Commerce official expects higher penalties for violations of U.S. export controls; Shein must satisfy both the U.S. and China to pull off its IPO; and U.S. lawmakers work to further limit U.S. investment in Chinese tech sector.
